Lannett Company, Inc.
Lannett Company, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 1942, Lannett has established itself as a leader in the development, manufacturing, and distribution of generic pharmaceuticals, primarily focusing on oral solid dosage forms. With a strong operational presence across various regions, the company is dedicated to providing high-quality, affordable medications that meet the needs of patients and healthcare providers. Lannett's core product offerings include a diverse range of generic drugs, which are distinguished by their rigorous quality standards and commitment to innovation. The company has achieved significant milestones, including strategic acquisitions that have expanded its product portfolio and market reach. Recognised for its reliability and expertise, Lannett continues to strengthen its position in the competitive pharmaceutical landscape, making a meaningful impact on public health.
DitchCarbon Score
How does Lannett Company, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Lannett Company, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Lannett Company, Inc.'s reported carbon emissions
Lannett Company, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Lannett may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). As the pharmaceutical industry increasingly prioritises sustainability, Lannett's absence of emissions data and climate commitments may reflect a need for enhanced transparency and action in addressing climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Lannett Company, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
